Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vir Biotechnology Inc shares valued at $401,585 were sold by SVF Endurance (Cayman) Ltd on Oct 27 ’25. At $6.05 per share, SVF Endurance (Cayman) Ltd sold 66,403 shares. The insider’s holdings dropped to 14,598,536 shares worth approximately $86.28 million following the completion of this transaction.
Also, SVF Endurance (Cayman) Ltd sold 46,696 shares, netting a total of over 278,285 in proceeds. Following the sale of shares at $5.96 each, the insider now holds 14,664,939 shares.
Before that, SVF Endurance (Cayman) Ltd had sold 154,383 shares from its account. In a trade valued at $924,723, the 10% Owner traded Vir Biotechnology Inc shares for $5.99 each. Upon closing the transaction, the insider’s holdings decreased to 154,383 shares, worth approximately $86.95 million.
As published in their initiating research note from Evercore ISI on September 03, 2025, Vir Biotechnology Inc [VIR] has been an Outperform and the price target has been revised to $12. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late August. As of January 29, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for VIR. Earlier on September 08, 2023, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for VIR stock which previously was a “a Buy”.
Analyzing VIR Stock Performance
On last trading session, Vir Biotechnology Inc [NASDAQ: VIR] plunged -8.09% to $5.91. The stock’s lowest price that day was $5.87, but it reached a high of $6.5 in the same session. During the last five days, there has been a drop of approximately -3.43%. Over the course of the year, Vir Biotechnology Inc shares have dropped approximately -20.99%. Shares of the company reached a 52-week high of $14.45 on 01/08/25 and a 52-week low of $4.16 on 08/11/25.
Support And Resistance Levels for Vir Biotechnology Inc (VIR)
According to the 24-hour chart, there is a support level at 5.69, which, if violated, would cause prices to drop to 5.46. In the upper region, resistance lies at 6.32. The next price resistance is at 6.72. RSI (Relative Strength Index) is 51.83 on the 14-day chart, showing neutral technical sentiment.
Is Vir Biotechnology Inc subject to short interest?
Stocks of Vir Biotechnology Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.91 million shares to 10.94 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 11.85 million shares. A decline of -8.34% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.32 of the overall float, the days-to-cover ratio (short ratio) decline to 8.32.
Which companies own the most shares of Vir Biotechnology Inc (VIR)?
In terms of Vir Biotechnology Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 86.63% from the previous closing price of $6.43. Analysts anticipate Vir Biotechnology Inc stock to reach 12 by 2025, with the lowest price target being 12. In spite of this, 10 analysts ranked Vir Biotechnology Inc stock as Buy at the end of 2025. On March 06, 2023, JP Morgan assigned a price target of “an Overweight” to the stock and upgraded coverage with a $34.
